Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats.
Gene regulation in the cardiovascular tissues of diabetic subjects has been reported to be altered. To examine abnormal activities in transcription factors as a possible cause of this altered gene regulation, we studied the activity of two redox-sensitive transcription factors--nuclear factor-kappaB (NF-kappaB) and activating protein-1 (AP-1)--and the change in the mRNA content of heme oxygenase-1, which is regulated by these transcription factors in the cardiac tissues of rats with streptozotocin-induced diabetes. Increased activity of NF-kappaB and AP-1 but not nuclear transcription-activating factor, as determined by an electrophoretic mobility shift assay, was found in the hearts of 4-week diabetic rats. Glycemic control by a subcutaneous injection of insulin prevented these diabetes-induced changes in transcription factor activity. In accordance with these changes, the mRNA content of heme oxygenase-1 was increased fourfold in 4-week diabetic rats and threefold in 24-week diabetic rats as compared with control rats (P < 0.01 and P < 0.05, respectively). Insulin treatment also consistently prevented changes in the mRNA content of heme oxygenase-1. The oral administration of an antioxidant, probucol, to these diabetic rats partially prevented the elevation of the activity of both NF-kappaB and AP-1, and normalized the mRNA content of heme oxygenase-1 without producing any change in the plasma glucose concentration. These results suggest that elevated oxidative stress is involved in the activation of the transcription factors NF-kappaB and AP-1 in the cardiac tissues of diabetic rats, and that these abnormal activities of transcription factors could be associated with the altered gene regulation observed in the cardiovascular tissues of diabetic rats.
Nishio
Y
Y
Third Department of Medicine, Shiga University of Medical Science, Ohtsu, Japan. nishio@belle.shiga-med.ac.jp
Kashiwagi
A
A
Taki
H
H
Shinozaki
K
K
Maeno
Y
Y
Kojima
H
H
Maegawa
H
H
Haneda
M
M
Hidaka
H
H
Yasuda
H
H
Horiike
K
K
Kikkawa
R
R
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000235:genetics* / Q000378:metabolism*; D015870:Gene Expression / Q000502:physiology; D006321:Heart / Q000503:physiopathology*; D006419:Heme Oxygenase (Decyclizing) / Q000235:genetics; D051547:Heme Oxygenase-1; D008054:Lipid Peroxides / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010088:Oxidoreductases / Q000235:genetics; D011341:Probucol / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology*
D000975:Antioxidants; D008054:Lipid Peroxides; D012333:RNA, Messenger; D014157:Transcription Factors; D010088:Oxidoreductases; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; D011341:Probucol